These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 30167646)

  • 21. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
    Del Trigo M; Bergeron S; Bernier M; Amat-Santos IJ; Puri R; Campelo-Parada F; Altisent OA; Regueiro A; Eigler N; Rozenfeld E; Pibarot P; Abraham WT; Rodés-Cabau J
    Lancet; 2016 Mar; 387(10025):1290-7. PubMed ID: 27025435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results.
    Urey MA; Hibbert B; Jorde U; Eckman P; Simard T; Labinaz M; Nazer B; Wiley M; Gupta B; Sauer A; Shah H; Sorajja P; Pineda AM; Missov E; Mahmud E; Kahwash R; Lilly S; Latib A; Murthy S; Fam N; Garcia S; Chung ES; Klein L; Cheng R; Houston BA; Amoroso NS; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Schwartz JG; Aldaia L; Koulogiannis K; Gray WA; Zahr F
    Eur J Heart Fail; 2024 Apr; 26(4):1065-1077. PubMed ID: 38606485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.
    Kosowski M; Kübler P; Kołodziej A; Krakowiak B; Kustrzycka-Kratochwil D; Sławin J; Sokolski M; Biegus J; Zymliński R; Banasiak W; Ponikowski P; Reczuch K
    Kardiol Pol; 2017; 75(8):736-741. PubMed ID: 28541594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: Rationale, Design and Lead-in Phase Results of the REBALANCE-HF Trial.
    Fudim M; Litwin SE; Borlaug BA; Mohan RC; Price MJ; Fail P; Zirakashvili T; Shaburishvili T; Goyal P; Hummel SL; Patel RB; Reddy VY; Burkhoff D; Patel MR; Somo SI; Shah SJ
    J Card Fail; 2024 Jul; 30(7):877-889. PubMed ID: 38211934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial Fibrillation Burden and Atrial Shunt Therapy in Heart Failure With Preserved Ejection Fraction.
    Patel RB; Reddy VY; Komtebedde J; Wegerich SW; Sekaric J; Swarup V; Walton A; Laurent G; Chetcuti S; Rademann M; Bergmann M; McKenzie S; Bugger H; Bruno RR; Herrmann HC; Nair A; Gupta DK; Lim S; Kapadia S; Gordon R; Vanderheyden M; Noel T; Bailey S; Gertz ZM; Trochu JN; Cutlip DE; Leon MB; Solomon SD; van Veldhuisen DJ; Auricchio A; Shah SJ
    JACC Heart Fail; 2023 Oct; 11(10):1351-1362. PubMed ID: 37480877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.
    Fudim M; Fail PS; Litwin SE; Shaburishvili T; Goyal P; Hummel SL; Borlaug BA; Mohan RC; Patel RB; Mitter SS; Klein L; Rocha-Singh K; Patel MR; Reddy VY; Burkhoff D; Shah SJ
    Eur J Heart Fail; 2022 Aug; 24(8):1410-1414. PubMed ID: 35598154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure.
    Hibbert B; Zahr F; Simard T; Labinaz M; Nazer B; Sorajja P; Eckman P; Pineda AM; Missov E; Mahmud E; Schwartz J; Gupta B; Wiley M; Sauer A; Jorde U; Latib A; Kahwash R; Lilly S; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Aldaia L; Koulogiannis K; Gray WA;
    JACC Cardiovasc Interv; 2023 Jun; 16(11):1369-1380. PubMed ID: 36989271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [InterAtrial Shunt Device in diastolic heart failure].
    Hasenfuß G; Jacobshagen C
    Internist (Berl); 2018 Oct; 59(10):1054-1062. PubMed ID: 30194481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR-HF trial.
    D'Amario D; Meerkin D; Restivo A; Ince H; Sievert H; Wiese A; Schaefer U; Trani C; Bayes-Genis A; Leyva F; Whinnett ZI; Di Mario C; Jonas M; Manhal H; Amat-Santos IJ; Del Trigo M; Gal TB; Avraham BB; Hasin T; Feickert S; D'Ancona G; Altisent OA; Koren O; Caspi O; Abraham WT; Crea F; Anker SD; Kornowski R; Perl L;
    Eur J Heart Fail; 2023 Jun; 25(6):902-911. PubMed ID: 37092287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study.
    Paitazoglou C; Bergmann MW; Özdemir R; Pfister R; Bartunek J; Kilic T; Lauten A; Schmeisser A; Zoghi M; Anker SD; Sievert H; Mahfoud F;
    Eur J Heart Fail; 2021 May; 23(5):800-810. PubMed ID: 33555114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
    Litwin SE; Komtebedde J; Seidler T; Borlaug BA; Winkler S; Solomon SD; Eicher JC; Mazimba S; Khawash R; Sverdlov AL; Hummel SL; Bugger H; Boenner F; Hoendermis E; Cikes M; Demers C; Silva G; van Empel V; Starling RC; Penicka M; Cutlip DE; Leon MB; Kitzman DW; van Veldhuisen DJ; Shah SJ;
    Eur J Heart Fail; 2024 Jan; 26(1):177-189. PubMed ID: 37989800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
    Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
    EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.
    Rodés-Cabau J; Lindenfeld J; Abraham WT; Zile MR; Kar S; Bayés-Genís A; Eigler N; Holcomb R; Núñez J; Lee E; Perl ML; Moravsky G; Pfeiffer M; Boehmer J; Gorcsan J; Bax JJ; Anker S; Stone GW
    Eur J Heart Fail; 2024 Apr; 26(4):1078-1089. PubMed ID: 38561314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
    Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
    JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.
    Simard T; Labinaz M; Zahr F; Nazer B; Gray W; Hermiller J; Chaudhry SP; Guimaraes L; Philippon F; Eckman P; Rodés-Cabau J; Sorajja P; Hibbert B
    JACC Cardiovasc Interv; 2020 May; 13(10):1236-1247. PubMed ID: 32438996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial pressure is associated with iatrogenic atrial septal defect after mitral valve clip.
    Ikenaga H; Hayashi A; Nagaura T; Yamaguchi S; Yoshida J; Rader F; Siegel RJ; Kar S; Shiota T
    Heart; 2019 Jun; 105(11):864-872. PubMed ID: 30482796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
    Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
    JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
    JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Efficacy of Interatrial Shunt Devices in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Abouzid MR; Ali K
    Cardiol Rev; 2024 Feb; ():. PubMed ID: 38323875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.